(Q64354524)
Statements
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of Ustekinumab in Adult Japanese Subjects With Severe Atopic Dermatitis (English)
0 references
September 2013
0 references
December 2014
0 references
79
0 references
20 year
0 references
65 year
0 references